1. Competition and collaboration in health care: reconciling the irreconcilable? Lessons from The Netherlands

   • Marco Varkevisser
   • Frédérique Franken
   • Erik Schut

   Editorial 08 July 2023 Pages: 1019 - 1021

2. Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries

   • Olina Efthymiadou

   Original Paper Open access 11 October 2022 Pages: 1023 - 1031

   

3. The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease

   • Zuzana Špacírová
   • Stephen Kaptoge
   • David Epstein

   Original Paper 14 October 2022 Pages: 1033 - 1045

   

4. Estimating healthcare expenditures after becoming divorced or widowed using propensity score matching

   • Iris Meulman
   • Bette Loef
   • Ellen Uiters

   Original Paper Open access 17 October 2022 Pages: 1047 - 1060

   

5. Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy

   • India Flint
   • Jasmina Medjedovic
   • Louise Longworth

   Original Paper 19 October 2022 Pages: 1061 - 1072

   

6. Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries

   • Przemysław Holko
   • Paweł Kawalec
   • Małgorzata Mossakowska

   Original Paper Open access 19 October 2022 Pages: 1073 - 1083

   

7. Do not PIMP my nursing home ride! The impact of Potentially Inappropriate Medications Prescribing on residents’ emergency care use

   • Thomas Rapp
   • Jonathan Sicsic
   • Yves Rolland

   Original Paper 21 October 2022 Pages: 1085 - 1100

   

8. The effects of an increase in the retirement age on health care costs: evidence from administrative data

   • Johannes Geyer
   • Mara Barschkett
   • Anna Hammerschmid

   Original Paper Open access 23 October 2022 Pages: 1101 - 1120

   

9. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study

   • Ingrid A. Cox
   • Barbara de Graaff
   • Andrew J. Palmer

   Original Paper Open access 27 October 2022 Pages: 1121 - 1139

   

10. Can drones save lives and money? An economic evaluation of airborne delivery of automated external defibrillators

    • Johann W. A. Röper
    • Katharina Fischer
    • Steffen Fleßa

    Original Paper Open access 30 October 2022 Pages: 1141 - 1150

    

11. The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review

    • Michela Meregaglia
    • Elena Nicod
    • Michael Drummond

    Original Paper Open access 05 November 2022 Pages: 1151 - 1216

    

12. What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains

    • Michał Jakubczyk

    Original Paper Open access 08 November 2022 Pages: 1217 - 1233

    

13. “COVID-19 and income inequality in OECD countries:” A methodological comment

    • Oded Stark

    Commentary Open access 23 June 2023 Pages: 1235 - 1237

14. COVID-19 and income inequality in OECD countries: a methodological comment—a reply

    • John Wildman

    Reply 17 June 2023 Pages: 1239 - 1241

15. Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment

    • Afschin Gandjour

    Commentary Open access 24 June 2023 Pages: 1243 - 1244

16. Does health technology assessment compromise access to pharmaceuticals?

    • Melanie Büssgen
    • Tom Stargardt

    Reply Open access 19 June 2023 Pages: 1245 - 1248